GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017 Mar;45(3):486-552. \[[PubMed: 28098591](https://pubmed.ncbi.nlm.nih.gov/28098591)\] 19. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M., Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001 Nov 08;345(19):1368-77. \[[PubMed: 11794169](https://pubmed.ncbi.nlm.nih.gov/11794169)\] 20. Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med. 2015 Nov;43(11):2292-302. \[[PubMed: 26323041](https://pubmed.ncbi.nlm.nih.gov/26323041)\] 21. Annane D. Corticosteroids for septic shock. Crit Care Med. 2001 Jul;29(7 Suppl):S117-20. \[[PubMed: 11445745](https://pubmed.ncbi.nlm.nih.gov/11445745)\] 22. Annane D, Renault A, Bellissant E. Glucocorticoids with or without Fludrocortisone in Septic Shock. N Engl J Med. 2018 Aug 30;379(9):895-6. \[[PubMed: 30179381](https://pubmed.ncbi.nlm.nih.gov/30179381)\] 23. Cardenas-Garcia J, Schaub KF, Belchikov YG, Narasimhan M, Koenig SJ, Mayo PH. Safety of peripheral intravenous administration of vasoactive medication. J Hosp Med. 2015 Sep;10(9):581-5. \[[PubMed: 26014852](https://pubmed.ncbi.nlm.nih.gov/26014852)\] 24. Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators. Intensive Care Med. 2015 Sep;41(9):1549-60. \[[PubMed: 25952825](https://pubmed.ncbi.nlm.nih.gov/25952825)\] 25. Osborn TM. Severe Sepsis and Septic Shock Trials (ProCESS, ARISE, ProMISe): What is Optimal Resuscitation? Crit Care Clin. 2017 Apr;33(2):323-344. \[[PubMed: 28284298](https://pubmed.ncbi.nlm.nih.gov/28284298)\] **Disclosure:** Sidharth Mahapatra declares no relevant financial relationships with ineligible companies. **Disclosure:** Alan Heffner declares no relevant financial relationships with ineligible companies.